Marker combination of product for relieving hypercoagulable state of lung cancer, establishment and application method of curative effect discrimination model and traditional Chinese medicine combination
The invention discloses a marker combination of a product for relieving a hypercoagulable state of lung cancer, establishment and application methods of a curative effect discrimination model and a traditional Chinese medicine composition, the marker combination comprises D-D and FIB, based on clini...
Gespeichert in:
Hauptverfasser: | , , , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention discloses a marker combination of a product for relieving a hypercoagulable state of lung cancer, establishment and application methods of a curative effect discrimination model and a traditional Chinese medicine composition, the marker combination comprises D-D and FIB, based on clinical real diagnosis and treatment data, two specific indexes D-D and FIB are obtained after screening, and the curative effect discrimination model can be used for treating the hypercoagulable state of lung cancer. A logistic regression model is established after multi-factor analysis and is used for judging the curative effect of intervening the hypercoagulable state, and compared with traditional index detection, the method has better accuracy and feasibility. Furthermore, based on the clinical curative effect, association rule analysis is performed on the used traditional Chinese medicine prescription according to the traditional Chinese medicine syndrome type, a corresponding traditional Chinese medicine composi |
---|